The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Abstract
Background Both weight loss and gastrointestinal surgery for obesity can cause liver disease, making their role in the treatment of obesity-related liver disease controversial. Methods Six hundred eighty-nine severely obese women (n=551) and men (n=138), BMI=47+/-9 kg.m(-2) (mean+/-SD), without known liver disease, underwent biliopancreatic diversion (BPD) with liver biopsy. Fourteen patients (2%) had cryptogenic cirrhosis, 11 of whom underwent multiple repeat biopsies. After 38+/-18 kg weight loss, 104 of the 689 patients underwent routine second biopsies during reoperations 41+/-25 months after BPD. All biopsy specimens were graded for steatosis, fibrosis, and inflammation by a blinded hepatopathologist. Results All 689 patients lost weight accompanied by improvements in the metabolic syndrome. Among the 104 patients who underwent reoperation, severe fibrosis (grade 3-5) decreased in 28 whereas mild fibrosis (grade 1-2) appeared in 42. Increased fibrosis was related to low-normal serum albumin, uncontrolled diarrhea, low intake of alcohol, and menopausal status. Fibrosis and inflammation decreased over time (P<.01). The 11 patients with cirrhosis exhibited decreased fibrosis from a mean grade 5 to grade 3, as well as reduced inflammation, Mallory bodies, and glycogenated nuclei. Seven patients had disappearance and 2 regression of nodules and fibrous bridging. Conclusions The metabolic syndrome of obesity is a determinant of liver fibrosis and cirrhosis, treatable by substantial weight loss after malabsorptive surgery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, one series found fibrosis scores worsened in 40% of patients (improved in 27%) despite reduced steatosis [53].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
In the citing paper
“However, its complexity, risks of malabsorption and its nutritional consequences, and the rare potential for accelerated liver fibrosis limit widespread adoption [53,58,59,60].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
In the citing paper
“Accordingly, BPD-DS leads to resolution of steatohepatitis in a majority of patients and can even regress advanced disease [53,54,55].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [53]
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Bravo, A. A., Sheth, S. G., & Chopra, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440706 · Cited by 2,083
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,609
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
Pratt, D. S., & Kaplan, M. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421707 · Cited by 1,203
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, É., Thibault, V., Theodorou, I. D., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 969
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 944
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 929
A Test for Symmetry in Contingency Tables
Bowker, A. H. (1948) · Journal of the American Statistical Association · doi:10.1080/01621459.1948.10483284 · Cited by 760
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Marceau, P., Biron, S., Hould, F. S., Marceau, S., Simard, S., Thung, S. N., & Kral, J. G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5661 · Cited by 633
Self-citationWeight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
MacDonald, K. G., Long, S. D., Swanson, M. S., Brown, B. M., Morris, P. G., Dohm, G. L., & Pories, W. J. (1997) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(97)80112-6 · Cited by 503
Nonalcoholic Fatty Liver Disease
Clark, J. M., & Diehl, A. M. (2003) · JAMA · doi:10.1001/jama.289.22.3000 · Cited by 431
Hammel, P., Couvelard, A., O'Toole, D., Ratouis, A., Sauvanet, A., Fléjou, J. F., Degott, C., Belghiti, J., Bernades, P., Valla, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440604 · Cited by 427
Reid, A. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.27126 · Cited by 399
Biliopancreatic diversion for obesity at eighteen years
Scopinaro, N., Gianetta, E., Adami, G., Friedman, D., Traverso, E., Marinari, G. M., Cuneo, S., Vitale, B., Ballari, F., Colombini, M., et al. (1996) · Surgery · doi:10.1016/s0039-6060(96)80111-5 · Cited by 390
Risk factors of fibrosis in alcohol-induced liver disease
Raynard, B., Balian, A., Fallik, D., Capron, F., Bédossa, P., Chaput, J., & Naveau, S. (2002) · Hepatology · doi:10.1053/jhep.2002.31782 · Cited by 387
Ikejima, K., Takei, Y., Honda, H., Hirose, M., Yoshikawa, M., Zhang, Y., Lang, T., Fukuda, T., Yamashina, S., Kitamura, T., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.32995 · Cited by 386
Saxena, N. K., Ikeda, K., Rockey, D. C., Friedman, S. L., & Anania, F. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32029 · Cited by 382
Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon
LIEBER, C. S., Robins, S. J., Li, J., DeCarli, L. M., Mak, K. M., Fasulo, J. M., & Leo, M. A. (1994) · Gastroenterology · doi:10.1016/s0016-5085(94)95023-7 · Cited by 307
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
Cortez‐Pinto, H., Camilo, M., Baptista, A., Oliveira, A. G., & de Moura, M. C. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(99)80015-6 · Cited by 299
Reversibility of Hepatic Fibrosis in Autoimmune Hepatitis
Dufour, J., DeLellis, R., & Kaplan, M. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-11-199712010-00006 · Cited by 292
Valenti, L. V. C., Fracanzani, A. L., Dongiovanni, P., Santorelli, G., Branchi, A., Taioli, E., Fiorelli, G., & Fargion, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.31065 · Cited by 289
Idiopathic steatohepatitis in childhood: A multicenter retrospective study
Baldridge, A. D., Pérez‐Atayde, A. R., Graeme‐Cook, F., Higgins, L., & Lavine, J. E. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70156-7 · Cited by 281
CEACAM1 regulates insulin clearance in liver
Poy, M. N., Yang, Y., Rezaei, K., Fernström, M. A., Lee, A. D., Kido, Y., Erickson, S. K., & Najjar, S. M. (2002) · Nature Genetics · doi:10.1038/ng840 · Cited by 269
Resistin, Obesity, and Insulin Resistance — The Emerging Role of the Adipocyte as an Endocrine Organ
Shuldiner, A. R., Yang, R., & Gong, D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111013451814 · Cited by 263
Ford, E. S., Galuska, D. A., Gillespie, C., Will, J. C., Giles, W. H., & Dietz, W. H. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112898 · Cited by 247
Rosmond, R., Chagnon, Y. C., Holm, G., Chagnon, M., Përusse, L., Lindell, K., Carlsson, B., Bouchard, C., & Björntorp, P. A. (2000) · Obesity Research · doi:10.1038/oby.2000.24 · Cited by 247
Luyckx, F., Lefebvre, P. J., & Scheen, A. J. (2000) · PubMed · Cited by 244
Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C
Arthur, M. J. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.33367 · Cited by 238
van Dielen, F., Veer, C. V. ′., Schols, A. M. W. J., Soeters, P. B., Buurman, W. A., & Greve, J.-W. M. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801825 · Cited by 237
Drenick, E. J., Fisler, J. S., & Johnson, D. G. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80403-4 · Cited by 226
Torjesen, P. A., Birkeland, K. I., Anderssen, S. A., Hjermann, I., Holme, I., & Urdal, P. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.26 · Cited by 196
Fatty liveran additional and treatable feature of the insulin resistance syndrome
Knobler, H. (1999) · QJM · doi:10.1093/qjmed/92.2.73 · Cited by 196
Body fat topography as an independent predictor of fatty liver
Kral, J. G., Schaffner, F., Pierson, R. N., & Wang, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90210-f · Cited by 176
Self-citationAlcohol Consumption and Alcoholic Liver Disease: Evidence of a Threshold Level of Effects of Ethanol
Savolainen, V. T., Liesto, K. K., Männikkö, A., Penttilä, A., & Karhunen, P. J. (1993) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb05673.x · Cited by 168
Insulin resistance, iron, and the liver
Ferrannini, E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02397-7 · Cited by 165
Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass
Silverman, E. M., Sapala, J. A., & Appelman, H. D. (1995) · American Journal of Clinical Pathology · doi:10.1093/ajcp/104.1.23 · Cited by 164
Evidence for mitochondrial DNA damage by lipid peroxidation
Hruszkewycz, A. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81207-5 · Cited by 158
Yang, S. Q., Lin, H. Z., Hwang, J., Chacko, V. P., & Diehl, A. M. (2001) · PubMed · Cited by 153
Kral, J. G. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70183-3 · Cited by 130
Self-citationMarceau, P., Hould, F. S., Lebel, S., Marceau, S., & Biron, S. (2001) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70187-0 · Cited by 128
Self-citationLeptin, obesity, and liver disease
Kaplan, L. M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70272-0 · Cited by 121
Unsuspected Cirrhosis Discovered During Elective Obesity Operations
Brolin, R. E. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.1.84 · Cited by 118
Steatohepatitis and fatal hepatic failure after biliopancreatic diversion.
Grimm, I. S., Schindler, W. R., & Haluszka, O. (1992) · PubMed · Cited by 110
Leptin and liver fibrosis: A matter of fat
Marra, F. (2002) · Gastroenterology · doi:10.1053/gast.2002.33369 · Cited by 92
Inhibition of rat liver fibrogenesis through noradrenergic antagonism
Dubuisson, L., Desmoulière, A., Decourt, B., Evadé, L., Bedin, C., Boussarie, L., Barrier, L., Vidaud, M., & Rosenbaum, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31166 · Cited by 85
Metabolic correlates of eating behavior in severe obesity
Kral, J., Buckley, M., Kissileff, H. R., & Schaffner, F. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801469 · Cited by 82
Self-citationCapron, J., Delamarre, J., Dupas, J., Braillon, A., Degott, C., & Quenum, C. (1982) · Digestive Diseases and Sciences · doi:10.1007/bf01296926 · Cited by 79
Long-Term Consequences After Jejunoileal Bypass for Morbid Obesity
Hocking, M. P., Davis, G. L., Franzini, D. A., & Woodward, E. R. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026698602714 · Cited by 77
Hepatic lipid metabolism in severe human obesity
Kral, J. G., Lundholm, K., Björntorp, P. A., Sjöström, L., & Scherstén, T. (1977) · Metabolism · doi:10.1016/0026-0495(77)90020-8 · Cited by 67
Self-citationBiliopancreatic Diversion, with Distal Gastrectomy, 250 cm and 50 cm Limbs: Long-term Results
Marceau, S., Biron, S., Lagacé, M., Hould, F., Potvin, M., Bourque, R. A., & Marceau, P. (1995) · Obesity Surgery · doi:10.1381/096089295765557683 · Cited by 63
Self-citationAlcohol Consumption in the Severely Obese: Relationship with the Metabolic Syndrome
Dixon, J. B., Dixon, M. E., & O’Brien, P. E. (2002) · Obesity Research · doi:10.1038/oby.2002.33 · Cited by 59
Liver Transplantation After Jejunoileal Bypass for Morbid Obesity
Lowell, J. A., Surendra, S., Ghalib, R., Caldwell, C., White, F. V., Peters, M., & Howard, T. K. (1997) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)00894-8 · Cited by 55
Hypothalamic-Pituitary-Adrenal Axis Function and the Metabolic Syndrome X of Obesity
Gohil, B. C., Rosenblum, L. A., Coplan, J. D., & Kral, J. G. (2001) · CNS Spectrums · doi:10.1017/s1092852900002121 · Cited by 45
Self-citationSoyer, M. T., Ceballos, R., & ALDRETE, J. S. (1976) · PubMed · Cited by 44
Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity
Hamilton, D. L., Vest, T. K., Brown, B. S., Shah, A. N., Menguy, R. B., & Chey, W. Y. (1983) · Gastroenterology · doi:10.1016/0016-5085(83)90032-x · Cited by 44
Fogel, M. R., Ravitch, M. M., & Adibi, S. A. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80351-4 · Cited by 38
Styblo, T. M., Martin, S., & Kaminski, D. L. (1984) · PubMed · Cited by 16
Moderate alcohol drinking: Effects on the heart and liver
Brenner, D. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20206 · Cited by 12
Research works printed but not linked: 1
- Bowker, 1948, Bowker's test of symmetry, J Am Statistical Assoc, 43, 572, 10.2307/2280710 · DOI
Cited by
Sorted by citations
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,428
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Meta-Analysis: Surgical Treatment of Obesity
Maggard, M. A., Shugarman, L. R., Suttorp, M. J., Maglione, M., Sugerman, H. J., Livingston, E. H., Nguyen, N. T., Li, Z., Mojica, W., Hilton, L. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00013 · Cited by 1,567
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez‐Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,083
Pouwels, S., Sakran, N., Graham, Y. N. H., Leal, A., Pintar, T., Yang, W., Kassir, R., Singhal, R., Mahawar, K. K., & Ramnarain, D. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00980-1 · Cited by 912
Metadata
- Authors
- Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P.
- Affiliations
- State University of New York (US)
- Corresponding author
- Kral, John G
- Venue
- Surgery
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 135
- Issue
- 1
- Pages
- 48-58
- ISSN
- 0039-6060 (ISSN-L)
- OpenAlex
- W2075060360
- Cited by
- 322
- References
- 69
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 4 · 2022: 10 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 7 · 2017: 13 · 2016: 11 · 2015: 21 · 2014: 23 · 2013: 9 · 2012: 14
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Surgery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- metabolic syndrome, obesity, liver fibrosis, liver cirrhosis, biliopancreatic diversion, bariatric surgery, weight loss, malabsorptive surgery, obesity-related liver disease, liver biopsy, steatosis, liver inflammation, serum albumin, menopause, fibrosis regression
- MeSH terms
- Adult, Biopsy, Fatty Liver, Female, Hepatitis, Humans, Liver, Liver Cirrhosis, Male, Middle Aged, Obesity, Morbid, Reoperation, Weight Loss, Biliopancreatic Diversion, Case-Control Studies, Single-Blind Method, Treatment Outcome, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review